Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade
Related Experiment Video
Updated: Dec 6, 2025

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
Muhammad Sohail1, Wenna Guo1, Zhiyong Li1
1School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Yantai University, Yantai, China.
Abstract:
In recent years, due to the shortcomings of conventional chemotherapy, such as poor bioavailability, low treatment index, and unclear side effects, the focus of cancer research has shifted to new nanocarriers of chemotherapeutic drugs. By using biodegradable materials, nanocarriers generally have the advantages of good biocompatibility, low side effects, targeting, controlled release profile, and improved efficacy. More to the point, nanocarrier based anti-cancer drug delivery systems clearly show the potential to overcome the problems associated with conventional chemotherapy. In order to promote the in-depth research and development in this field, we herein summarized and analyzed various nanocarrier based drug delivery systems for cancer therapy, including the concepts, types, characteristics, and preparation methods. The active and passive targeting mechanisms of cancer therapy were also included, along with a brief introduction of the research progress of nanocarriers used for anti-cancer drug delivery in the past decade.
Insights
New nanocarriers offer improved cancer treatment by overcoming conventional chemotherapy limitations. These biodegradable drug delivery systems provide better biocompatibility, targeted action, and controlled release for enhanced efficacy.
Area of Science:
- Biomedical Engineering
- Materials Science
- Oncology
Background:
- Conventional chemotherapy faces challenges including poor bioavailability, low treatment index, and unclear side effects.
- Nanocarrier-based drug delivery systems are emerging as a promising alternative in cancer therapy.
- Biodegradable nanocarriers offer advantages like biocompatibility, reduced side effects, and targeted drug release.
Purpose of the Study:
- To review and analyze various nanocarrier-based drug delivery systems for cancer therapy.
- To discuss the concepts, types, characteristics, and preparation methods of these nanocarriers.
- To explore active and passive targeting mechanisms in nanocarrier-mediated cancer treatment.
Main Methods:
- Literature review and analysis of nanocarrier-based drug delivery systems.
- Summary of research progress in nanocarrier applications for anti-cancer drug delivery over the past decade.
- Inclusion of active and passive targeting strategies.
Main Results:
- Nanocarriers demonstrate potential to overcome limitations of conventional chemotherapy.
- Biodegradable nanocarriers exhibit improved biocompatibility, efficacy, and controlled release profiles.
- Various nanocarrier types, characteristics, and preparation methods are discussed.
Conclusions:
- Nanocarrier-based drug delivery systems represent a significant advancement in cancer therapy.
- These systems offer a promising approach to enhance anti-cancer drug efficacy and patient outcomes.
- Further research and development in this field are crucial for clinical translation.
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

